Guideline on aspects of cancer-related venous thrombosis

British Committee for Standards in Haematology

This aims to provide healthcare professionals with clear guidance on prevention and management of venous thromboembolism (VTE) in patients with cancer and to advise on an approach to screening for cancer in patients with unprovoked VTE in whom cancer was not initially suspected.

Restarting Anticoagulant Treatment After Intracranial Haemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality and Bleeding: A Nationwide Cohort Study

Circulation

Danish study (n=1752) found AF patients with intracranial haemorrhage (ICH) are at very high risk of ischaemic stroke/mortality, if not on antithrombotic. Oral anticoagulant was linked to reduction in this risk, supporting feasability of its reintroduction post-ICH.

Drug-related problems in a clinical setting: a literature review and cross-sectional study evaluating factors to identify patients at risk

European Journal of Hospital Pharmacy

A narrative review of 21 papers found that although risk factors associated with drug-related problems (DRPs) differed greatly among these publications, comorbidity, polypharmacy and the use of specific drugs (antithrombotics, antidiabetics) were frequently associated with DRPs.

The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at:

http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services